About Guardant Health, Inc.

Guardant Health, Inc. (NASDAQ: GH) is a Healthcare company (Medical - Diagnostics & Research) with a market capitalization of $22.4B. Its Maz Rating is 4.35 out of 5 (A, Strong Buy), ranked against the other companies in its sector.

Factor scores: Valuation 1.07, Growth 4.53, Profitability 3.73, Financial Health 3.10, Momentum 4.58 (as of 2026-10-16).

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Exchange

NASDAQ

Country

US

CEO

Helmy Eltoukhy

Employees

2,498

IPO date

2018-10-04